Blonski M, Obara T, Brzenczek C, Pouget C, Dillier C, Meyer M, Lavigne L, Forthoffer N, Broussois A, Gauchotte G, Baron MH, Rech F, Mézières S, Gaudeau Y, Verger A, Vogin G, Anxionnat R, Moureaux JM, Taillandier L

Front Oncol. 2022 ;12:827897

GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation.

Hirtz A, Lebourdais N, Rech F, Bailly Y, Vaginay A, Smaïl-Tabbone M, Dubois-Pot-Schneider H, Dumond H

Cells. 2021 12 7;10(12):

Effects of Carbidopa Premedication on F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis.

Bros M, Zaragori T, Rech F, Blonski M, Hossu G, Taillandier L, Marie PY, Verger A

Cancers (Basel). 2021 Oct 24;13(21):

Impaired Set-Shifting from Dorsal Stream Disconnection: Insights from a European Series of Right Parietal Lower-Grade Glioma Resection.

Hartung SL, Mandonnet E, de Witt Hamer P, Klein M, Wager M, Rech F, Pallud J, Pessanha Viegas C, Ille S, Krieg SM, Robe PA, van Zandvoort MJE

Cancers (Basel). 2021 Jul 3;13(13):

F-FDOPA PET for the non-invasive prediction of glioma molecular parameters: a radiomics study.

Zaragori T, Oster J, Roch V, Hossu G, Chawki MB, Grignon R, Pouget C, Gauchotte G, Rech F, Blonski M, Taillandier L, Imbert L, Verger A

J Nucl Med. 2021 May 20;:

Dynamic F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?

Zaragori T, Doyen M, Rech F, Blonski M, Taillandier L, Imbert L, Verger A

Front Oncol. 2021 ;11:735257

Astrocytoma: A Hormone-Sensitive Tumor?

Hirtz A, Rech F, Dubois-Pot-Schneider H, Dumond H

Int J Mol Sci. 2020 Nov 30;21(23):

New insights into the neural foundations mediating movement/language interactions gained from intrasurgical direct electrostimulations.

Rech F, Wassermann D, Duffau H

Brain Cogn. 2020 07;142:105583

Use of static and dynamic [F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progression.

Zaragori T, Ginet M, Marie PY, Roch V, Grignon R, Gauchotte G, Rech F, Blonski M, Lamiral Z, Taillandier L, Imbert L, Verger A

EJNMMI Res. 2020 May 29;10(1):56

Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study.

Gauchotte G, Peyre M, Pouget C, Cazals-Hatem D, Polivka M, Rech F, Varlet P, Loiseau H, Lacomme S, Mokhtari K, Kalamarides M, Bielle F

J. Neuropathol. Exp. Neurol.. 2020 May 24;:

Brain abscesses and intracranial empyema due to dental pathogens: Case series.

Kichenbrand C, Marchal A, Mouraret A, Hasnaoui N, Guillet J, Rech F, Phulpin B

Int J Surg Case Rep. 2020 Mar 28;69:35-38

Adult Diffuse Low-Grade Gliomas: 35-Year Experience at the Nancy France Neurooncology Unit.

Obara T, Blonski M, Brzenczek C, Mézières S, Gaudeau Y, Pouget C, Gauchotte G, Verger A, Vogin G, Moureaux JM, Duffau H, Rech F, Taillandier L

Front Oncol. 2020 ;10:574679

Metastatic glioblastoma cells in brain biopsy rinse fluid.

Humbert C, Gérard D, Rech F, Gauchotte G, Broséus J, Lesesve JF

Cytopathology. 2019 Sep 28;:

Ki-67 and MCM6 labelling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network.

Pouget C, Hergalant S, Lardenois E, Lacomme S, Houlgatte R, Carpentier C, Dehais C, Rech F, Taillandier L, Sanson M, Appay R, Colin C, Figarella-Branger D, Battaglia-Hsu SF, Gauchotte G,

Brain Pathol.. 2019 Sep 27;:

Integration of dynamic parameters in the analysis of F-FDopa PET imaging improves the prediction of molecular features of gliomas.

Ginet M, Zaragori T, Marie PY, Roch V, Gauchotte G, Rech F, Blonski M, Lamiral Z, Taillandier L, Imbert L, Verger A

Eur. J. Nucl. Med. Mol. Imaging. 2019 Sep 16;:

A probabilistic map of negative motor areas of the upper limb and face: a brain stimulation study.

Rech F, Herbet G, Gaudeau Y, Mézières S, Moureau JM, Moritz-Gasser S, Duffau H

Brain. 2019 04 1;142(4):952-965

[Use of the PELICAN software for the creation and export of standardized pathology reports in central nervous system tumors: Example of meningiomas].

Yguel C, Clauzon D, Lacomme S, Lomazzi S, Lardenois E, Pouget C, Taillandier L, Rech F, Rigau V, Vignaud JM, Bauchet L, Gauchotte G

Ann Pathol. 2019 Mar 7;:

A high F-FDOPA uptake is associated with a slow growth rate in diffuse Grade II-III gliomas.

Isal S, Gauchotte G, Rech F, Blonski M, Planel S, Chawki MB, Karcher G, Marie PY, Taillandier L, Verger A

Br J Radiol. 2018 Apr;91(1084):20170803

Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol.

Rofes A, Mandonnet E, Godden J, Baron MH, Colle H, Darlix A, de Aguiar V, Duffau H, Herbet G, Klein M, Lubrano V, Martino J, Mathew R, Miceli G, Moritz-Gasser S, Pallud J, Papagno C, Rech F, Robert E, Rutten GJ, Santarius T, Satoer D, Sierpowska J, Smits A, Skrap M, Spena G, Visch E, De Witte E, Zetterling M, Wager M

Acta Neurochir (Wien). 2017 07;159(7):1167-1178

Intraoperative identification of the negative motor network during awake surgery to prevent deficit following brain resection in premotor regions.

Rech F, Duffau H, Pinelli C, Masson A, Roublot P, Billy-Jacques A, Brissart H, Civit T

Neurochirurgie. 2017 Jun;63(3):235-242

Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.

Gauchotte G, Hergalant S, Vigouroux C, Casse JM, Houlgatte R, Kaoma T, Helle D, Brochin L, Rech F, Peyre M, Labrousse F, Vallar L, Gueant JL, Vignaud JM, Battaglia-Hsu SF

J. Pathol.. 2017 May;: